在癌症和固体器官移植中采用免疫效应细胞疗法:一篇评论
Brittany Schreiber1, Sudipta Tripathi1, Sarah Nikiforow2
1Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, MA.
Seminars in nephrology
|March 30, 2024
概括
收养细胞疗法,包括病毒特异性T细胞疗法和CAR T细胞疗法,在预防脏移植接受者的癌症方面表现有前途. 这些创新的治疗方法旨在克服免疫抑制.
科学领域:
- 免疫学 免疫学 免疫学
- 在瘤学瘤学.
- 移植医学 移植医学
背景情况:
- 癌症是接受脏移植患者的主要死亡原因.
- 免疫抑制是防止器官排斥所必需的,通过削弱免疫监测来增加癌症风险.
- 收养细胞疗法提供了一种潜在的新策略来对抗移植后恶性瘤.
研究的目的:
- 审查采用细胞疗法的发展.
- 专注于病毒特异性T细胞疗法和仿真抗原受体 (CAR) T细胞疗法.
- 探索它们在固体器官移植 (SOT) 中的应用.
主要方法:
- 审查关于采用细胞疗法的现有文献.
- 专注于病毒特异性T细胞和CAR T细胞疗法开发.
- 在SOT环境中分析当前的应用和挑战.
主要成果:
- 收养细胞疗法是新兴的模式,在SOT中具有潜力.
- 病毒特异性T细胞和CAR T细胞疗法是其中的领先例子.
- 在将这些疗法应用于实体器官移植接受者方面存在挑战.
结论:
- 收养细胞疗法在SOT接受者的癌症管理方面具有重大前景.
- 需要进一步的研究和开发来克服应用挑战.
- 这些疗法代表了改善移植患者治疗结果的未来方向.
相关概念视频
Cell-mediated Immune Responses
68.2K
Overview
68.2K
Tumor Immunotherapy
523
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
523
Tissue Transplantation
366
Tissue transplantation is a significant medical procedure involving the transfer of cells, tissues, or organs from a donor to a recipient, with the primary aim of restoring lost functions. This procedure is crucial in treating a broad spectrum of diseases, including kidney diseases, liver failure, heart disease, and certain types of cancers.
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...
366
Cytotoxic T Cells-mediated Immune Response
907
Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
907
Bone Marrow Sampling and Transplants
328
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
328
Regulation of Hematopoietic Stem Cells
3.2K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.2K


